Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Geoerger

Showing results (31-40 of 179) with videos related to

Pageof 18
Sort By:
International Journal of Cancer|April 5, 2008
EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenograftsBirgit Geoerger, Nathalie Gaspar, Paule Opolon, et al.
Pediatric Blood & Cancer|December 31, 2013
Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomasFrancisco Bautista, Angelo Paci, Veronique Minard-Colin, et al.
Cancer Genetics|April 29, 2017
Genomic diagnostics leading to the identification of a TFG-ROS1 fusion in a child with possible atypical meningiomaMaria Rossing, Christina Westmose Yde, Astrid Sehested, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Population pharmacokinetics and pharmacogenetics of imatinib in children and adultsAurélie Petain, Darouna Kattygnarath, Julie Azard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 5, 2018
Discovery of New Fusion Transcripts in a Cohort of Pediatric Solid Cancers at Relapse and Relevance for Personalized MedicineCélia Dupain, Anne C Harttrampf, Yannick Boursin, et al.
Cancer Treatment Reviews|March 17, 2010
The role of the 'innovative therapies for children with cancer' (ITCC) European consortiumC Michel Zwaan, Pamela Kearns, Huib Caron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2011
Population analysis of erlotinib in adults and children reveals pharmacokinetic characteristics as the main factor explaining tolerance particularities in childrenMelanie White-Koning, Elodie Civade, Birgit Geoerger, et al.
Neuro-Oncology Practice|December 29, 2025
Dabrafenib in pediatric patients with <i>BRAF</i> V600 mutation-positive high-grade glioma: Results from a phase 1/2a single-arm studyBirgit Geoerger, Lucas Moreno, Eric Bouffet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2022
Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric <i>BRAF</i> V600-Mutant Low-Grade GliomaEric Bouffet, Birgit Geoerger, Christopher Moertel, et al.
European Journal of Cancer (Oxford, England : 1990)|October 29, 2011
Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcomaBirgit Geoerger, Mark W Kieran, Stephan Grupp, et al.
Pageof 18

Showing results (31-40 of 179) with videos related to

Sort By:
Pageof 18
International Journal of Cancer|April 5, 2008
EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenograftsBirgit Geoerger, Nathalie Gaspar, Paule Opolon, et al.
Pediatric Blood & Cancer|December 31, 2013
Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomasFrancisco Bautista, Angelo Paci, Veronique Minard-Colin, et al.
Cancer Genetics|April 29, 2017
Genomic diagnostics leading to the identification of a TFG-ROS1 fusion in a child with possible atypical meningiomaMaria Rossing, Christina Westmose Yde, Astrid Sehested, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Population pharmacokinetics and pharmacogenetics of imatinib in children and adultsAurélie Petain, Darouna Kattygnarath, Julie Azard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 5, 2018
Discovery of New Fusion Transcripts in a Cohort of Pediatric Solid Cancers at Relapse and Relevance for Personalized MedicineCélia Dupain, Anne C Harttrampf, Yannick Boursin, et al.
Cancer Treatment Reviews|March 17, 2010
The role of the 'innovative therapies for children with cancer' (ITCC) European consortiumC Michel Zwaan, Pamela Kearns, Huib Caron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2011
Population analysis of erlotinib in adults and children reveals pharmacokinetic characteristics as the main factor explaining tolerance particularities in childrenMelanie White-Koning, Elodie Civade, Birgit Geoerger, et al.
Neuro-Oncology Practice|December 29, 2025
Dabrafenib in pediatric patients with <i>BRAF</i> V600 mutation-positive high-grade glioma: Results from a phase 1/2a single-arm studyBirgit Geoerger, Lucas Moreno, Eric Bouffet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2022
Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric <i>BRAF</i> V600-Mutant Low-Grade GliomaEric Bouffet, Birgit Geoerger, Christopher Moertel, et al.
European Journal of Cancer (Oxford, England : 1990)|October 29, 2011
Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcomaBirgit Geoerger, Mark W Kieran, Stephan Grupp, et al.
Pageof 18